Table 6.

Main Discussion Points from the Workshop

Discussion	Point Comments
Simple & low cost	Methods for scaffold characterization methods must be simple & low cost; complex measurements are difficult to standardize; TEMPs costs are becoming prohibitive
Need scaffold reference materials	To enable measurement comparisons between different labs
Need to promote the use of standards	The use of standards must be promoted at universities Must demonstrate the value of standards, standards are for all R&D - not just regulatory ASTM must have joint symposia with other societies
Need to assess use of & need for scaffold standards	Should include database searching (pubmed, patents) Cost-benefit analysis is required for ASTM standards through case studies Majority of scaffold standards are guides and are unlikely to be cited
Specific application	Each scaffold has to be tailored for a specific unmet need, there can be no universal cell or universal scaffold
CLINICAL is most important	BIOmaterials & bioMATERIALs are both incorrect
Measurements provide information about a specimen’s state	A measurement assesses the state of a specimen and does not predict efficacy; meeting a standard indicates that it is same as before
Length scales	What are the important scaffold-based metrics at different length scales (nano/micro/macro) that influence clinical outcomes?